Get 40% Off
👀 👁 🧿 All eyes on Biogen, up +4,56% after posting earnings. Our AI picked it in March 2024.
Which stocks will surge next?
Unlock AI-picked Stocks

Express Scripts (ESRX) In Focus: Stock Moves 5.5% Higher

Published 10/30/2017, 08:33 AM
Updated 07/09/2023, 06:31 AM

Express Scripts Holding Company (NASDAQ:ESRX) was a big mover last session, as the company saw its shares rise over 5% on the day. The move came on solid volume too with far more shares changing hands than in a normal session. This stock, which remained volatile and traded within the range of $56.81–$64.01 in the past one-month time frame, witnessed a sharp increase on Friday.

The Zacks Consensus Estimate for the current quarter has seen six upward versus two downward movements over past two months. Although our consensus estimate has remained unchanged over the same time frame, this upward revisions suggest that more solid trading could be ahead for Express Scripts.So make sure to keep an eye on this stock going forward to see if this recent jump can turn into more strength down the road.

Express Scripts currently has a Zacks Rank #3 (Hold) while its Earnings ESP is positive.

Express Scripts Holding Company Price and Consensus

A better ranked stock in the Medical Services industry is PRA Health Sciences, Inc. (NASDAQ:PRAH) which carries a Zacks Rank #1 (Strong Buy). You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.

Is ESRX going up? Or down? Predict to see what others think:Up or Down

Zacks’ Best Private Investment Ideas

While we are happy to share many articles like this on the website, our best recommendations and most in-depth research are not available to the public.

Starting today, for the next month, you can follow all Zacks' private buys and sells in real time. Our experts cover all kinds of trades… from value to momentum . . . from stocks under $10 to ETF and option moves . . . from stocks that corporate insiders are buying up to companies that are about to report positive earnings surprises. You can even look inside exclusive portfolios that are normally closed to new investors.

Click here for Zacks' private trades >>

3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or remove ads .


Express Scripts Holding Company (ESRX): Free Stock Analysis Report

PRA Health Sciences, Inc. (PRAH): Free Stock Analysis Report

Original post

Zacks Investment Research

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.